Home / Technology / AI-Designed Dog Cancer Vaccine Launched: Startup Gamgee
AI-Designed Dog Cancer Vaccine Launched: Startup Gamgee
12 Aug
Summary
- Startup Gamgee uses AI to create personalized mRNA cancer vaccines for dogs.
- Founder Paul Conyngham claims AI contributed to his dog Rosie's tumor reduction.
- Gamgee is recruiting for clinical trials in Australia and accepts global cases.
Paul Conyngham has launched Gamgee, a startup focused on developing personalized mRNA cancer vaccines for dogs. The company leverages AI and computational genomics, with Conyngham citing its role in his own dog Rosie's tumor reduction. Gamgee is now recruiting for its initial clinical trials in Australia, while also accepting cases globally.
The startup's mission extends beyond canine treatments, aiming to develop personalized therapies for various diseases and species, including humans. Gamgee collaborates with Australian universities, including the University of Queensland and the University of New South Wales. The company aims to provide a rapid vaccine turnaround, estimated at four weeks for veterinarians.
Despite the grand ambitions, questions remain about the precise role of AI in Rosie's treatment, as it was administered alongside other therapies. Researchers have noted the difficulty in attributing improvement solely to the AI-designed vaccine. Gamgee's long-term goals include applying its AI-driven genetic treatment approach to human diseases.
